Canavan disease (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Canavan disease" in English language version.

refsWebsite

Global rank English rank

19nih.gov

4^th place

10doi.org

2^nd place

3semanticscholar.org

11^th place

8^th place

2rarediseases.org

5,181^st place

3,260^th place

2canavanfoundation.org

low place

1ku.edu

3,496^th place

2,340^th place

1web.archive.org

1^st place

1omim.org

4,380^th place

4,305^th place

1medlineplus.gov

1,581^st place

1,299^th place

1latimes.com

22^nd place

19^th place

1canavan.org

low place

1the-scientist.com

7,827^th place

5,905^th place

canavan.org

"Our Story: The Search for a Cure". Canavan Research Foundation. Retrieved Nov 22, 2010.^{[permanent dead link]}

canavanfoundation.org

"Screening | Canavan Foundation". www.canavanfoundation.org. Retrieved 2021-08-13.
"Am I At Risk? | Canavan Foundation". www.canavanfoundation.org. Retrieved 2021-03-30.

doi.org

Namboodiri, Am; Peethambaran, A; Mathew, R; Sambhu, Pa; Hershfield, J; Moffett, Jr; Madhavarao, Cn (June 2006). "Canavan disease and the role of N-acetylaspartate in myelin synthesis". Molecular and Cellular Endocrinology. 252 (1–2): 216–23. doi:10.1016/j.mce.2006.03.016. PMID 16647192. S2CID 12255670.
Assadi, M.; Janson, C.; Wang, D. J.; Goldfarb, O.; Suri, N.; Bilaniuk, L.; Leone, P. (Jul 2010). "Lithium citrate reduces excessive intra-cerebral N-acetyl aspartate in Canavan disease". European Journal of Paediatric Neurology. 14 (4): 354–359. doi:10.1016/j.ejpn.2009.11.006. PMID 20034825.
Janson, Christopher; McPhee, Scott; Bilaniuk, Larissa; Haselgrove, John; Testaiuti, Mark; Freese, Andrew; Wang, Dah-Jyuu; Shera, David; Hurh, Peter; Rupin, Joan; Saslow, Elizabeth; Goldfarb, Olga; Goldberg, Michael; Larijani, Ghassem; Sharrar, William; Liouterman, Larisa; Camp, Angelique; Kolodny, Edwin; Samulski, Jude; Leone, Paola (20 July 2002). "Clinical protocol. Gene Therapy of Canavan Disease: AAV-2 Vector for Neurosurgical Delivery of Aspartoacylase Gene (ASPA) to the Human Brain". Human Gene Therapy. 13 (11): 1391–1412. doi:10.1089/104303402760128612. PMID 12162821. S2CID 21318465.
Leone, P.; Shera, D.; McPhee, S. W. J.; Francis, J. S.; Kolodny, E. H.; Bilaniuk, L. T.; Wang, D.-J.; Assadi, M.; Goldfarb, O.; Goldman, H. W.; Freese, A.; Young, D.; During, M. J.; Samulski, R. J.; Janson, C. G. (19 December 2012). "Long-Term Follow-Up After Gene Therapy for Canavan Disease". Science Translational Medicine. 4 (165): 165ra163. doi:10.1126/scitranslmed.3003454. PMC 3794457. PMID 23253610.
Canavan MM (1931). "Schilder's Encephalitis Periaxialis Diffusa. Report of a Case in a Child Aged Sixteen and One-Half Months". Archives of Neurology and Psychiatry. 25 (2): 299–308. doi:10.1001/archneurpsyc.1931.02230020085005.
Matalon, R (1997). "Canavan disease: diagnosis and molecular analysis". Genetic Testing. 1 (1): 21–5. doi:10.1089/gte.1997.1.21. PMID 10464621.
Colaianni, A; Chandrasekharan, S; Cook-Deegan, R (April 2010). "Impact of gene patents and licensing practices on access to genetic testing and carrier screening for Tay–Sachs and Canavan disease". Genetics in Medicine. 12 (4 Suppl): S5–S14. doi:10.1097/gim.0b013e3181d5a669. PMC 3042321. PMID 20393311.
Mathew R, Arun P, Madhavarao CN, Moffett JR, Namboodiri MA (2010). "Metabolic acetate therapy improves phenotype in the tremor rat model of Canavan disease". J Inherit Metab Dis. 33 (3): 195–210. doi:10.1007/s10545-010-9100-z. PMC 2877317. PMID 20464498.
Gessler, D. J.; Li, D.; Xu, H.; Su, Q.; Sanmiguel, J.; Tuncer, S.; Moore, C.; King, J.; Matalon, R.; Gao, G. (2017). "Redirecting N-acetylaspartate metabolism in the central nervous system normalizes myelination and rescues Canavan disease". JCI Insight. 2 (3): e90807. doi:10.1172/jci.insight.90807. PMC 5291725. PMID 28194442.
Stecula A, Hussain M, Viola RE (2020). "Discovery of Novel Inhibitors of a Critical Brain Enzyme Using a Homology Model and a Deep Convolutional Neural Network". J Med Chem. 63 (16): 8867–8875. doi:10.1021/acs.jmedchem.0c00473. PMID 32787146. S2CID 221123632.

ku.edu

login.ku.edu

Bokhari, Maria R.; Debopam, Samanta; Bokhari, Syed Rizwan A. (July 6, 2020). "StatPearls". National Center for Biotechnology Information. Archived from the original on 2021-06-10. Retrieved 2021-04-06.

latimes.com

"Families Sue Over Gene Study of Canavan Disease". Los Angeles Times. November 19, 2000. Retrieved January 28, 2024.

medlineplus.gov

MedlinePlus Medical Encyclopedia. (2019). Myelin. In Medlineplus.gov. Retrieved June 26, 2021, https://medlineplus.gov/ency/article/002261.htm

nih.gov

pubmed.ncbi.nlm.nih.gov

Namboodiri, Am; Peethambaran, A; Mathew, R; Sambhu, Pa; Hershfield, J; Moffett, Jr; Madhavarao, Cn (June 2006). "Canavan disease and the role of N-acetylaspartate in myelin synthesis". Molecular and Cellular Endocrinology. 252 (1–2): 216–23. doi:10.1016/j.mce.2006.03.016. PMID 16647192. S2CID 12255670.
Matalon, Reuben; Delgado, Lisvania; Michals-Matalon, Kimberlee (1993), Adam, Margaret P.; Ardinger, Holly H.; Pagon, Roberta A.; Wallace, Stephanie E. (eds.), "Canavan Disease", GeneReviews®, Seattle (WA): University of Washington, Seattle, PMID 20301412, retrieved 2021-09-10
Assadi, M.; Janson, C.; Wang, D. J.; Goldfarb, O.; Suri, N.; Bilaniuk, L.; Leone, P. (Jul 2010). "Lithium citrate reduces excessive intra-cerebral N-acetyl aspartate in Canavan disease". European Journal of Paediatric Neurology. 14 (4): 354–359. doi:10.1016/j.ejpn.2009.11.006. PMID 20034825.
Janson, Christopher; McPhee, Scott; Bilaniuk, Larissa; Haselgrove, John; Testaiuti, Mark; Freese, Andrew; Wang, Dah-Jyuu; Shera, David; Hurh, Peter; Rupin, Joan; Saslow, Elizabeth; Goldfarb, Olga; Goldberg, Michael; Larijani, Ghassem; Sharrar, William; Liouterman, Larisa; Camp, Angelique; Kolodny, Edwin; Samulski, Jude; Leone, Paola (20 July 2002). "Clinical protocol. Gene Therapy of Canavan Disease: AAV-2 Vector for Neurosurgical Delivery of Aspartoacylase Gene (ASPA) to the Human Brain". Human Gene Therapy. 13 (11): 1391–1412. doi:10.1089/104303402760128612. PMID 12162821. S2CID 21318465.
Leone, P.; Shera, D.; McPhee, S. W. J.; Francis, J. S.; Kolodny, E. H.; Bilaniuk, L. T.; Wang, D.-J.; Assadi, M.; Goldfarb, O.; Goldman, H. W.; Freese, A.; Young, D.; During, M. J.; Samulski, R. J.; Janson, C. G. (19 December 2012). "Long-Term Follow-Up After Gene Therapy for Canavan Disease". Science Translational Medicine. 4 (165): 165ra163. doi:10.1126/scitranslmed.3003454. PMC 3794457. PMID 23253610.
Matalon, R (1997). "Canavan disease: diagnosis and molecular analysis". Genetic Testing. 1 (1): 21–5. doi:10.1089/gte.1997.1.21. PMID 10464621.
Colaianni, A; Chandrasekharan, S; Cook-Deegan, R (April 2010). "Impact of gene patents and licensing practices on access to genetic testing and carrier screening for Tay–Sachs and Canavan disease". Genetics in Medicine. 12 (4 Suppl): S5–S14. doi:10.1097/gim.0b013e3181d5a669. PMC 3042321. PMID 20393311.
Mathew R, Arun P, Madhavarao CN, Moffett JR, Namboodiri MA (2010). "Metabolic acetate therapy improves phenotype in the tremor rat model of Canavan disease". J Inherit Metab Dis. 33 (3): 195–210. doi:10.1007/s10545-010-9100-z. PMC 2877317. PMID 20464498.
Gessler, D. J.; Li, D.; Xu, H.; Su, Q.; Sanmiguel, J.; Tuncer, S.; Moore, C.; King, J.; Matalon, R.; Gao, G. (2017). "Redirecting N-acetylaspartate metabolism in the central nervous system normalizes myelination and rescues Canavan disease". JCI Insight. 2 (3): e90807. doi:10.1172/jci.insight.90807. PMC 5291725. PMID 28194442.
Stecula A, Hussain M, Viola RE (2020). "Discovery of Novel Inhibitors of a Critical Brain Enzyme Using a Homology Model and a Deep Convolutional Neural Network". J Med Chem. 63 (16): 8867–8875. doi:10.1021/acs.jmedchem.0c00473. PMID 32787146. S2CID 221123632.

ncbi.nlm.nih.gov

Matalon, Reuben; Delgado, Lisvania; Michals-Matalon, Kimberlee (1993), Adam, Margaret P.; Ardinger, Holly H.; Pagon, Roberta A.; Wallace, Stephanie E. (eds.), "Canavan Disease", GeneReviews®, Seattle (WA): University of Washington, Seattle, PMID 20301412, retrieved 2021-09-10
Leone, P.; Shera, D.; McPhee, S. W. J.; Francis, J. S.; Kolodny, E. H.; Bilaniuk, L. T.; Wang, D.-J.; Assadi, M.; Goldfarb, O.; Goldman, H. W.; Freese, A.; Young, D.; During, M. J.; Samulski, R. J.; Janson, C. G. (19 December 2012). "Long-Term Follow-Up After Gene Therapy for Canavan Disease". Science Translational Medicine. 4 (165): 165ra163. doi:10.1126/scitranslmed.3003454. PMC 3794457. PMID 23253610.
Colaianni, A; Chandrasekharan, S; Cook-Deegan, R (April 2010). "Impact of gene patents and licensing practices on access to genetic testing and carrier screening for Tay–Sachs and Canavan disease". Genetics in Medicine. 12 (4 Suppl): S5–S14. doi:10.1097/gim.0b013e3181d5a669. PMC 3042321. PMID 20393311.
Mathew R, Arun P, Madhavarao CN, Moffett JR, Namboodiri MA (2010). "Metabolic acetate therapy improves phenotype in the tremor rat model of Canavan disease". J Inherit Metab Dis. 33 (3): 195–210. doi:10.1007/s10545-010-9100-z. PMC 2877317. PMID 20464498.
Gessler, D. J.; Li, D.; Xu, H.; Su, Q.; Sanmiguel, J.; Tuncer, S.; Moore, C.; King, J.; Matalon, R.; Gao, G. (2017). "Redirecting N-acetylaspartate metabolism in the central nervous system normalizes myelination and rescues Canavan disease". JCI Insight. 2 (3): e90807. doi:10.1172/jci.insight.90807. PMC 5291725. PMID 28194442.

ghr.nlm.nih.gov

Reference, Genetics Home. "Canavan disease". Genetics Home Reference. Retrieved 2017-06-14.
"Canavan disease". Genetics Home Reference. Retrieved 10 May 2020.

rarediseases.info.nih.gov

"Canavan disease; Spongy degeneration of the central nervous system". NCATS program. Genetic and rare diseases information center. Retrieved 17 April 2018.

nlm.nih.gov

Dr. Myrtelle May Canavan National Library of Medicine: Changing the Face of Medicine: Physicians. Accessed July 21, 2009.

omim.org

Online Mendelian Inheritance in Man (OMIM): 271900

rarediseases.org

"Canavan Disease". NORD (National Organization for Rare Disorders). Retrieved 2021-04-06.
"Canavan Disease – NORD (National Organization for Rare Disorders)". NORD (National Organization for Rare Disorders). Retrieved 2017-06-14.

semanticscholar.org

api.semanticscholar.org

Namboodiri, Am; Peethambaran, A; Mathew, R; Sambhu, Pa; Hershfield, J; Moffett, Jr; Madhavarao, Cn (June 2006). "Canavan disease and the role of N-acetylaspartate in myelin synthesis". Molecular and Cellular Endocrinology. 252 (1–2): 216–23. doi:10.1016/j.mce.2006.03.016. PMID 16647192. S2CID 12255670.
Janson, Christopher; McPhee, Scott; Bilaniuk, Larissa; Haselgrove, John; Testaiuti, Mark; Freese, Andrew; Wang, Dah-Jyuu; Shera, David; Hurh, Peter; Rupin, Joan; Saslow, Elizabeth; Goldfarb, Olga; Goldberg, Michael; Larijani, Ghassem; Sharrar, William; Liouterman, Larisa; Camp, Angelique; Kolodny, Edwin; Samulski, Jude; Leone, Paola (20 July 2002). "Clinical protocol. Gene Therapy of Canavan Disease: AAV-2 Vector for Neurosurgical Delivery of Aspartoacylase Gene (ASPA) to the Human Brain". Human Gene Therapy. 13 (11): 1391–1412. doi:10.1089/104303402760128612. PMID 12162821. S2CID 21318465.
Stecula A, Hussain M, Viola RE (2020). "Discovery of Novel Inhibitors of a Critical Brain Enzyme Using a Homology Model and a Deep Convolutional Neural Network". J Med Chem. 63 (16): 8867–8875. doi:10.1021/acs.jmedchem.0c00473. PMID 32787146. S2CID 221123632.

the-scientist.com

"Slow March Toward a Canavan Cure". The Scientist Magazine®.

web.archive.org

Bokhari, Maria R.; Debopam, Samanta; Bokhari, Syed Rizwan A. (July 6, 2020). "StatPearls". National Center for Biotechnology Information. Archived from the original on 2021-06-10. Retrieved 2021-04-06.